Coalition for the Advancement of Medical Research
Nonprofit profile at a glance
- EIN
- 522306688
- IRS 990-EZ coverage
- 2010–2013
- Forms available
- Form 990-EZ 2013
- Location
- Washington, DC, USA
- Phone
- 2022932856
- Rating
- 83
- Verdict
- STRONG
- Rating confidence
- Moderate
Reported finances
- Revenue
- $195
- Expenses
- $212,707
- Assets
- $0
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2013. Amounts in USD.
Leadership & pay
12 people listed
Executive titles in this filing
- AMY COMSTOCK RICK (PRESIDENT)
People named in this filing
- AMY COMSTOCK RICK (PRESIDENT)
- RHONDA NORSETTER (VP OPERATIONS/SECRETARY)
- ROSS FROMMER (VP FOR MEMBERSHIP)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2013. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To establish and support policies related to stem cell research; create and administer educational resources and activities related to stem cell research and to make such resources available to researchers and the general public; and to admister a website for the dissemination of educational and other information related to stem cell research.
What it reported doing in 2013
The coalition for the advancement of medical research (camr) led legal and public reactions to continuing stages in the sherley vs. Sebelius court challenge to federal funding of research involving embryonic stem cell research. In this leadership role, we communicated information about the legal challenges and decisions to our membership, the public and media, and capitol hill, and worked with our attorney to provide supportive information to the department of justice in defense of the funding guidelines.camr remained active in educating new and current members of congress on the science of regenerative medicine, and worked with leaders on the issue to host a briefing featuring a respected researcher in the field.the coalition also engaged in multiple state legislative and constitutional challenges to embryonic stem cell research, in states including Texas, New York, Mississippi, Minnesota, Oklahoma, and Michigan. As part of this effort, we engaged our membership and grassroots to impact state outcomes.
Operating model
- Revenue model
- Investment-supported. 100% of the money available for current operations came from recurring investment income.
- Distribution model
- Grant intermediary. The nonprofit sent 100% of its reported program spending out as grants.
The verdict
STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Expenses are high relative to revenue and revenue has declined or grown slowly.
Rating breakdown
- Financial Efficiency: 95
- Transparency & Controls: 82
- Sustainability: 7
- Growth: 40
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 87.5%; rating input score 87
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: -108,980.5%; rating input score 0; 0th percentile among comparable filings
- Total-asset coverage ratio: 0; rating input score 1; 1st percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 57; 57th percentile among comparable filings
Growth
- Program expense growth: 48.3% per year; rating input score 100; 91st percentile among comparable filings
- Revenue growth: -59.3% per year; rating input score 0; 7th percentile among comparable filings
- Asset growth: -42.6% per year; rating input score 0; 8th percentile among comparable filings
Details
- Where the money goes: 100% of revenue deployed · 87.5% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $186K in reported program spending
- Leadership: top reported pay $0 · 12 people listed
- Consistency: 9 of 9 current checks pass
- Schedules: 2 filed schedules
- Filing history: 4 filing years from 2010 to 2013
- Contacts: How to reach this organization
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Sustainability: Operating margin scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 1/100.
- High — Growth: Asset growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 57/100.